$NAUT

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (6m)

—

Win rate (6m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 23, 4:45 PM ET

$NAUTr/pennystocksDDbullish

u/Emotional-Breath-838 · 4h ago3 prior · awaiting results

Three proteomics biotech penny stocks: NAUT, QSI and PACB

Nautilus is pioneering the Voyager platform to decode the human proteome with ultra-high sensitivity and scale. Despite being pre-commercial with cash burn, the company has a clean balance sheet and solid reserves, positioned to benefit from the emerging single-molecule proteomics market.

Now $3.24as of Oct 23, 4:45 PM ET

original post →

$NAUTr/pennystocksBullishbullish

u/Confident_Garden_731 · 20d agono track record yet

NAUT nearly doubled in a week: real re-rating or momentum pop?

Recent analyst initiations and Nature Methods validation of Voyager platform signal a potential re-rating in proteomics. If Voyager scales to deliver ~20 proteoform assays by mid-2028, it could unlock material value for drug discovery and diagnostics, especially in neuro and oncology, though risks include minimal revenue, upcoming dilution, and biotech volatility.

At post $1.87Now $3.24+73.3% since postedas of Oct 23, 4:45 PM ET

1d-5.3%

3d-2.7%

1w+16.0%

1m—

3m—

6m—

1y—

original post →

End of results.